Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades
This article was originally published in The Pink Sheet Daily
Executive Summary
A criminal complaint charges Cheng Yi Liang with trading in the securities of five companies based on the status of their new drug applications, gaining more than $2 million.